Quarterly Newsletter

Welcome to the latest edition of our quarterly newsletter!  The ImmPort team is always working to bring you new data and features.  We are excited to share these highlights below to help you get the most out of your ImmPort experience.

What's New?   COVID-19 Studies    New Datasets   Upcoming Webinars
ImmPort & the Cancer Genomics Cloud Project

New COVID-19 Data Has Arrived!
Our latest data release contains more high-quality immunological COVID-19 data. View all COVID-19 datasets, or browse new COVID-19 studies below.  Additional ImmPort datasets are freely available upon registration and can be queried and downloaded using either a web browser or RESTful APIs. 

SDY1640: T and B cell responses to SARS-CoV-2 coronavirus.  Grifoni, et al., Cell, Jun 2020 New release - February 2020
SDY1641: Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.  Meng et al., Emerging Microbes and Infections, Dec 2020
SDY1648: Sex differences in immune responses to SARS-CoV-2 (Companion study to SDY1655).  Takahashi et al., Nature, Aug 2020
SDY1655: Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19.  Lucas et al., Nature, Aug 2020
SDY1662: An Inflammatory Cytokine Signature Predicts Covid-19 Severity And Survival.  del Valle et al., Nature Medicine, Oct 2020
SDY1667: Cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Mateus et al., Science, Oct 2020.  New release - February 2020
SDY1680: T cell and antibody functional correlates of severe COVID-19.
Click on a study number for more information
 

ImmPort & the Cancer Genomics Cloud Project
Rheumatology Data for Cancer Analysis
Cross-discipline collaboration can be a powerful tool for new discovery. ImmPort recently collaborated with the Seven Bridges Cancer Genomics Cloud (CGC) project to deploy a Jupyter notebook and detailed tutorial that demonstrates how to find and integrate multiple rheumatology datasets from ImmPort with CGC resources. Users can find the notebook by accessing the Public Projects section on the CGC portal, and selecting the project entitled "Rheumatology Data for Cancer Analysis from ImmPort". CGC portal login is required before accessing Public Projects.
 

New Webinar Series

Title: Exploring ImmPort's Open-access Immunological and Clinical Trial Datasets: An Introduction to Leveraging ImmPort Shared Data

Presented by ImmPort Team
ImmPort is thrilled to announce a new webinar series for researchers wanting to learn more about using ImmPort.  Sanchita Bhattacharya, ImmPort Science Program Lead from the University of California, San Francisco, Bakar Computational Health Sciences Institute, will be hosting a series of webinars throughout 2021. Webinar details and registration information for the first webinar are below.  See you at the webinar!
Share Your Data with ImmPort
Your data goes further when shared and can lead to innovative discoveries.  Join your research colleagues in sharing data through the ImmPort platform.  ImmPort team members are always happy to assist with data uploads.  Contact us at ImmPort_Helpdesk@immport.org
 
ImmPort contains: 480+ studies and 67K subjects for 114 diseases supported by 1900 experiments, 6M test results, and 1.2M laboratory results
See a Data Visualization of All Studies
Follow us on Facebook Follow us on Facebook
Follow us on Twitter Follow us on Twitter
ImmPort is a recommended data repository by PLoS One and Nature's Scientific Data, and holds the Core Trust Seal of Approval for Core Trustworthy Data Repositories
Copyright © 2021 ImmPort, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Our mailing address is:
ImmPort_Helpdesk@immport.org